Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · IEX Real-Time Price · USD
267.55
+3.58 (1.36%)
Jul 2, 2024, 4:00 PM EDT - Market closed

Bio-Rad Laboratories Revenue

Bio-Rad Laboratories had revenue of $2.61B in the twelve months ending March 31, 2024, down -6.25% year-over-year. Revenue in the quarter ending March 31, 2024 was $610.82M, a -9.75% decrease year-over-year. In the year 2023, Bio-Rad Laboratories had annual revenue of $2.67B, a decrease of -4.67%.

Revenue (ttm)
$2.61B
Revenue Growth
-6.25%
P/S Ratio
2.93
Revenue / Employee
$324,438
Employees
8,030
Market Cap
7.64B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.67B-130.99M-4.67%
Dec 31, 20222.80B-120.30M-4.12%
Dec 31, 20212.92B376.92M14.81%
Dec 31, 20202.55B233.97M10.12%
Dec 31, 20192.31B22.24M0.97%
Dec 31, 20182.29B129.26M5.98%
Dec 31, 20172.16B91.98M4.45%
Dec 31, 20162.07B48.73M2.41%
Dec 31, 20152.02B-155.60M-7.15%
Dec 31, 20142.18B42.35M1.99%
Dec 31, 20132.13B63.46M3.07%
Dec 31, 20122.07B-4.29M-0.21%
Dec 31, 20112.07B146.41M7.60%
Dec 31, 20101.93B142.87M8.01%
Dec 31, 20091.78B19.88M1.13%
Dec 31, 20081.76B303.31M20.76%
Dec 31, 20071.46B187.12M14.69%
Dec 31, 20061.27B92.95M7.87%
Dec 31, 20051.18B90.97M8.35%
Dec 31, 20041.09B110.38M11.27%
Dec 31, 2003979.63M114.63M13.25%
Dec 31, 2002865.01M47.50M5.81%
Dec 31, 2001817.51M91.63M12.62%
Dec 31, 2000725.88M170.49M30.70%
Dec 31, 1999555.40M107.54M24.01%
Dec 31, 1998447.86M20.95M4.91%
Dec 31, 1997426.91M8.13M1.94%
Dec 31, 1996418.79M22.17M5.59%
Dec 31, 1995396.62M41.32M11.63%
Dec 31, 1994355.30M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Henry Schein 12.45B
Exact Sciences 2.53B
Chemed 2.29B
HealthEquity 1.04B
Intra-Cellular Therapies 513.93M
Ascendis Pharma 357.63M
Legend Biotech 342.80M
Roivant Sciences 124.80M
Revenue Rankings